The success of albumin-based systems is evident in real-world applications like Abraxane, an albumin-bound paclitaxel formulation that has shown improved efficacy and reduced toxicity in cancer therapy compared to its conventional counterpart [112]. The gene discussed is ALB; the disease is cancer.